Myeloma Statistics: How Common Is Myeloma?
Myeloma, also known as multiple myeloma or plasma cell myeloma, is the third most common blood cancer (after lymphoma and leukemia) in the United States and constitutes approximately 1.4 percent of the estimated new cancer cases in 2014. Since 1975, overall myeloma incidence has increased nearly 1 percent annually. Overall mortality rates peaked in the mid-1990s and have fallen in recent years.
Men have a higher incidence of myeloma than women. In addition, African Americans have over twice the incidence and mortality rates of whites.
It is estimated that more than 24,000 individuals will be diagnosed with myeloma in the United States in 2014, and more than 11,000 will die from this disease.
Risk factors for myeloma include being middle aged or older, being black, being male, having been exposed to radiation or certain chemicals, and having a personal history of monoclonal gammopathy of undetermined significance (MGUS) or isolated plasmacytoma of the bone. There is no standard or routine screening test for myeloma. Standard treatments for myeloma include chemotherapy, corticosteroid therapy, targeted therapy, high-dose chemotherapy with stem cell transplant, biological therapy, radiation therapy, surgery, and watchful waiting.